Regular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.
This special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.
This cross-sectional retrospective study found comparable blood pressure control rates among patients with hypertension receiving primary care from a nurse practitioner versus a physician.
Weekend cardiac catheterization availability for inpatients reduced length of stay and maintained quality of care (no excess hazard for weekend cases), but costs were similar.
Anticoagulation clinics in an integrated healthcare system differed widely in their organization and management, but these differences were not consistently related to their performance.
A randomized controlled trial was conducted to compare the effectiveness of automated telephone and mail outreach to prompt compliance with periodic diabetes laboratory testing.
Gender differences were found in healthcare utilization in patients with type 2 diabetes mellitus in Germany, despite a high rate of enrollment in a disease management program.
Massachusetts is integrating HIV surveillance and leveraging electronic health record clinical data into their electronic disease case management system to enhance monitoring the HIV continuum of care.
Amending regulations to expand the “safe harbor” by allowing predeductible coverage of high-value services and medications for chronic diseases would provide Americans a plan option that better meets their clinical and financial needs.
The data-fueled healthcare revolution requires us to share data and share risk to ultimately share rewards andachieve Triple Aim goals.
We examine utilization, quality, and expenditures among Medicare beneficiaries receiving care at federally qualified health centers and compare outcomes among those attributed to 1 of 3 recognition programs versus none.
Use of Toyota production system methods as part of a nosocomial MRSA prevention initiative on a surgical unit improved quality of care in other areas.
Universal gene expression profiling of patients with stage II breast cancer resulted in outpatient savings of $11,000 (inclusive of testing costs) within 6 months of initiation of medical therapy.
Disease management programs for diabetes care based on bundled payment did not slow down the cost growth. Multimorbid adult patients with diabetes had largest cost growth.
A complex care management program implemented at 5 Next Generation accountable care organizations reduced all-cause inpatient admissions and total medical expenditures for participating beneficiaries.
In this retrospective cohort study of patients with newly diagnosed psoriatic arthritis, the authors examine the association of treatment selection and costs with physician specialty.